Week 3 Flashcards

(33 cards)

1
Q

features of autosomal recessive disorders

A

parents are carriers, males and females equally affected, parents might share an ancestor if gene is rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

modifier

A

gene or variant that modifies the expression of a phenotype assoc with a gene at a diff locus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

newborn screening

A

identifies conditions that can affect child’s long term health; early detection, diagnosis and intervention can prevent death and disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

kennedy disease

A

spinar and bulbur muscular atrophy, repeat in androgen receptor = androgen insensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

fragile x syndrome

A

worse in boys due to x inactivation, genetic disability, repeat –> hypermethylation of CpG upstream –> less FMRI protein translated. unstable repeats. anticipation = repeats enlarge with subsequent meiosis, so worsens with generations; in 5 prime UTR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

huntington’s disease

A

repeat in huntingtin gene in exon; causes poly glutamine which makes protein sticky; toxic gain of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

friedreich ataxia

A

repeat in intron of frataxin –> causes abnormal DNA –> decreased frataxin mRNA and protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

examples of anticipation

A

repeat expands over time; mytonic dystrophy, and fragile x syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

familial anytrophic lateral sclerosis (ALS)

A

dominant; gain of function toxic, incomplete penetrance, genetic heterogeneity (variants in multiple genes), variable expresivity, founder effects, gene SOD I, mutant SOD can not make Cu/Zn dimer –> so sequesters wrong protein/oxidized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

classic ether danios sequence

A

dominant; haploinsufficiency, genetic heterogeneity, dominant negative effect; mutation in COL genes; affect fiber collagen formation, interferes with normal collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

myotonic dystrophy

A

muscle weakness; repeat in 3 UTR; toxic gain of function; mutant RNA forms nuclear aggregates and sequesters proteins like muscleblind; anticipation; autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ALS

A

mutations in C9 gene; autosomal dominant; repeat in intron; could be gain of function or loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

marfan syndrome

A

dominant; variable expressivity, 25% of it is de novo mutation, variance in FBN I for fibrillin I (fibers in extracellular matrix); connective tissue disorder; cant sequester TGF so starts a cascade and makes a protease that degrades the matrix; dominant negative because mutant protein interferes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the 3 different kinds of mutations for de novo

A

new mutation in gamete made by the parent; made earlier during the development of the parent in a subset so could or could not be passed down; no mutation in parent and happens in embryo of child

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

proteus syndrome

A

dominant; overgrowth of tissues; somatic variation occurs early in development embryo of child; variance in Glu17Lys in AKT 1; AKT is upregulator that is overstimulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Incomplete penetrance

A

Occurs when individuals carrying a pathogenic variant do not express the clinical features normally associated with pathogenic variants in the gene

17
Q

Variable expressivity

A

Individuals with a particular genotype known to cause disease can exhibit one to many clinical features of that disease and also vary in severity, from mild to sever

18
Q

Modifier

A

A gene or variant that modifies the expression of a phenotype associated with a gene at a different locus

19
Q

Somatic variant:

A

The variant is not inherited from a parent; the mutation arises randomly in one cell during the early stages of development before birth. The proportion of cells that carry that variant is dependent on which stage during development the variant occurs; earlier = more cells and tissues, later = fewer cells and even just part of tissues.

20
Q

Germline variant:

A

The variant is inherited from a parent, variant is present in every cell in the body.

21
Q

Dominant negative

A

Mechanism by which a protein with an altered sequence due to a pathogenic variant interferes with
the protein made from the other, unaltered allele. Thus, the negative effect of the pathogenic variant is amplified, and the function of both alleles is disrupted.

22
Q

Haploinsufficiency:

A

A loss of function variant where the protein made from the other, unaltered allele is unable to
compensate or prevent the disease.

23
Q

Gain of function

A

Mechanism by which a pathogenic variant increases the normal function of the protein.

24
Q

pyridoxine dependent epilepsy

A

recessive; ALDH7A1 deficiency –> PLP deficiency; vitamin B6 makes PLP and stops seizures; loss of function; inborn error of metabolism; compound heterozygous variants common

25
Beta thalassemia
recessive; severe anemia; HBB variance; variable carrier frequencies; modifier alleles; genotype phenotype correlation -- some variants have a more severe phenotype; can be modified by HBA1 and HBA2 also by reducing alpha globin and increasing fetal beta globin (replacing the beta globin); leads to reduction of beta globin
26
sickle cell disease
HBB missense Glu6Val
27
cystic fibrosis
recessive; carrier frequencies vary between populations; newborn screening; modifier alleles; heterozygous selection advantage; variant in CFTR; chloride channel not functioning
28
Hardy weinberg
P^2 + 2pq + q^2 = 1. P^2 is frequency of AA. q^2 is frequency of aa.
29
spinal muscular atrophy
recessive; modifier alleles; newborn screening; gene duplications; deletion of exon 7 at SMN 1; but SMN 2 (copy) has a C to T mutation so it has exon 7; increased SMN 2 = milder disease
30
x linked dominant
male to male transmission. males have more severe phenotype than females; if mom is carrier than males and females have equal chance of getting; if dad has it, then NO affected sons, because dads pass down Y. if dad has it, females will have it.
31
x linked recessive
mostly males affected. heterozygous females are carriers and pass it down to males. can not be passed down from dad to his son. female can only have it, if both parents were carriers.
32
linkage analysis
the closer the genes the higher the possibility of linked transmission
33
high throughput or next generation sequencing analysis
all the genes in the genome can be simultaneously sequenced